BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils-Reference-Cited by-同舟云学术

BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils

Published:2017-04-20 Issue:11 Volume:72 Page:1666-1676
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Smiljkovic D.¹^ORCID,Blatt K.¹²,Stefanzl G.¹²,Dorofeeva Y.³,Skrabs C.¹,Focke‐Tejkl M.³,Sperr W. R.¹²,Jaeger U.¹²,Valenta R.³^ORCID,Valent P.¹²

Affiliation:

1. Department of Internal Medicine I Division of Hematology & Hemostaseology Medical University of Vienna Vienna Austria

2. Ludwig Boltzmann Cluster Oncology Medical University of Vienna Vienna Austria

3. Division of Immunopathology Department of Pathophysiology and Allergy Research Center for Pathophysiology, Immunology and Infectiology Medical University of Vienna Vienna Austria

Funder

Austrian Science Fund

Novartis

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.13166

Reference44 articles.

1. Cell Surface Structures on Human Basophils and Mast Cells: Biochemical and Functional Characterization

2. The human basophil: a new appreciation of its role in immune responses

3. Mast cells and mastocytosis

4. THE HIGH-AFFINITY IgE RECEPTOR (FcεRI): From Physiology to Pathology

5. Signal Transduction by the High-Affinity Immunoglobulin E Receptor FcεRI: Coupling Form to Function

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urticaria Beyond Omalizumab: What is Next?;Current Treatment Options in Allergy;2024-07-30

2. Bruton's tyrosine kinase inhibition for the treatment of allergic disorders;Annals of Allergy, Asthma & Immunology;2024-07

3. The role of Bruton's tyrosine kinase in pathogenesis of chronic spontaneous urticaria and the prospects for the use of new treatment;Russian Journal of Allergy;2024-06-16

4. New evidence in food allergies treatment;Current Opinion in Allergy & Clinical Immunology;2024-05-30

5. Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases;Autoimmunity Reviews;2024-05